Maze Therapeutics, Inc. · NASDAQ:MAZE
Dandekar Atul sold 7,500 Maze Therapeutics, Inc. shares (Form 4)
Traded Apr 29, 2026 · Filed May 1, 2026
On Apr 29, 2026, Dandekar Atul (CSBO) sold 7,500 Maze Therapeutics, Inc. shares at US$25.37 for US$190K under a trading plan, leaving 10,503 shares. Filed May 1, 2026 (Form 4).
- Sold
- 7,500 shares
- Price
- US$25.37
- Value
- US$190K
- Holding after
- 10,503 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CSBO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 29, 2026 | Common Stock | Option exercise | 7,500 | US$10.42 | 18,003 | Direct |
| Apr 29, 2026 | Common Stock | Sale | 7,500 | US$25.37 | 10,503 | Direct |
Source
Related
- Maze Therapeutics, Inc.
- Dandekar Atul
- Maze Therapeutics, Inc. shareholders
- Form 4 · Dandekar Atul · Oct 1, 2026
- Form 4 · Dandekar Atul · Sep 4, 2026
- Form 4 · Dandekar Atul · Sep 3, 2026
- Form 4 · Dandekar Atul · Aug 31, 2026
- Form 4 · Dandekar Atul · Jul 31, 2026
- Form 4 · Bernstein Harold · Oct 2, 2026
- Form 4 · Coloma Jason V · Oct 2, 2026
- Form 4 · Bernstein Harold · Sep 8, 2026
- Form 4 · Bernstein Harold · Sep 4, 2026
- Form 4 · Coloma Jason V · Sep 4, 2026